Medical device investigator site supporting a clinical study in India
INDIA • MEDICAL DEVICE • IVD • CLINICAL RESEARCH

Medical Device & IVD Clinical Research in India

Bioexcel supports Indian and international MedTech manufacturers with clinical investigations, PMCF, retrospective studies, IVD clinical performance programs, site feasibility, monitoring, clinical data management, biostatistics and regulatory evidence generation in India.

Our India delivery model combines suitable hospitals and investigators with centralized Bioexcel clinical, data, statistical and medical writing teams.

HomeMedical Device CRO India

Is Bioexcel a Medical Device CRO in India?

Yes. Bioexcel is a specialized medical device and IVD clinical research organization supporting clinical investigations, PMCF, IVD studies, monitoring, data management, biostatistics and medical writing through suitable Indian clinical sites and investigators.

Bioexcel Lifesciences & Research LLP is a specialized medical device and IVD clinical research organization supporting clinical investigations, PMCF, IVD performance studies, site operations, data management, biostatistics and regulatory evidence programs in India.

Content Managed By: Bioexcel India Clinical Operations & Regulatory TeamReviewed By: Amandeep Kaur, Director – Clinical OperationsLast Updated: 27 August 2026
Why India for MedTech Clinical Research

India Can Offer Strong Clinical Evidence Opportunities

Depending on the device, indication and study design, India may offer:

Medical device site feasibility assessment in India
  • Large patient populations
  • High procedure volumes
  • Diverse clinical populations
  • Tertiary hospitals
  • Super-specialty centers
  • Experienced investigators
  • Diagnostic laboratories
  • Long-term device-use records
  • Cost-efficient centralized operations
  • Access to prospective and retrospective evidence models

However, the right site must be selected according to the actual regulatory evidence requirement, not only the number of available patients.

The Bioexcel India Delivery Model

From Study Requirement to Clinical Evidence

01

Evidence Strategy

  • Device / IVD
  • Intended purpose
  • Regulatory market
  • Evidence gap
  • Study type
  • Clinical objective

Output: India Clinical Strategy

02

Site Feasibility

  • Patient population
  • Device-use history
  • Investigator experience
  • Procedure volume
  • Infrastructure
  • Ethics pathway
  • Recruitment potential

Output: Shortlisted Sites

03

Study Start-Up

  • Investigator documentation
  • Site documents
  • Ethics
  • Applicable regulatory steps
  • Contract
  • Budget
  • Training
  • Site initiation

Output: Activated Site(s)

04

Clinical Execution

  • Recruitment
  • Clinical procedures
  • Sample collection
  • Follow-up
  • Safety
  • Study coordination

Output: Clinical Data

05

Monitoring

  • Source-data review
  • Protocol compliance
  • Consent review
  • Safety
  • Device accountability
  • Query follow-up

Output: Quality-Controlled Study

06

Data & Statistics

  • eCRF / EDC
  • Data management
  • Database lock
  • Biostatistics

Output: Analysis-Ready Data

07

Regulatory Evidence

  • Clinical Investigation Report
  • CPSR
  • PMCF Evaluation Report
  • CER inputs
  • Regulatory responses

Output: Regulatory-Ready Evidence

What Clinical Research Services Does Bioexcel Provide in India?

Bioexcel supports India-based medical device and IVD clinical investigations, site feasibility, PMCF, retrospective studies, specimen programs, monitoring, EDC, clinical data management, biostatistics, medical writing and regulatory evidence integration.

What services does Bioexcel provide in India?

Bioexcel supports medical device clinical investigations, PMCF, retrospective studies, IVD performance programs, site feasibility, monitoring, data management, biostatistics and regulatory medical writing in India.

Does Bioexcel work with international sponsors?

Yes. Bioexcel supports international medical device and IVD manufacturers seeking clinical evidence generation in India, subject to the applicable study and regulatory requirements.

Can Bioexcel support global regulatory evidence using India studies?

Yes. Bioexcel can design India clinical programs around international evidence objectives, while the ultimate regulatory applicability of the data should be evaluated for the specific target market.

India Site Feasibility

Selecting the Right Hospital in India

Bioexcel site feasibility may assess:

Patient Population

  • Eligible patient volume
  • Disease prevalence
  • Monthly procedure volume
  • Follow-up potential
  • Competing studies

Investigator

  • Relevant specialty
  • Device/procedure experience
  • Clinical research experience
  • Availability
  • Interest

Infrastructure

  • Cath lab
  • Operating theatre
  • Imaging
  • ICU
  • Laboratory
  • Sample storage
  • Research staff

Operations

  • Ethics Committee
  • Contracts
  • Site budget
  • Monitoring access
  • Medical-record access
  • Data capabilities

Can Bioexcel Identify Hospitals and Investigators in India?

Yes. Bioexcel can conduct site feasibility based on indication, patient availability, procedure volume, investigator expertise, infrastructure, research experience and expected study timelines.

Sponsor-Selected Sites

Already Have a Hospital or Investigator?

Bioexcel can work with a site selected by the sponsor. Potential support includes:

  • Feasibility confirmation
  • Protocol implementation
  • Ethics coordination
  • Start-up
  • Site initiation
  • Monitoring
  • EDC
  • Data management
  • Statistics
  • Clinical reporting

Can Bioexcel Manage a Sponsor-Selected Site in India?

Yes. Bioexcel can provide operational, monitoring, data, statistical and reporting support for sponsor-selected hospitals or investigators depending on the agreed scope.

Single-Site Studies

One Site May Be Enough

A single-site study may be suitable where:

  • Patient volume is sufficient
  • Investigator expertise is concentrated
  • Recruitment targets are realistic
  • Required follow-up is available
  • Operational simplicity is desirable

Suitable For

  • Targeted PMCF
  • Certain IVD programs
  • Specialist procedures
  • Smaller prospective studies
  • Sponsor-selected hospitals
Multi-Site Studies

Multi-Site Clinical Programs Across India

Multiple sites may be required to:

  • Increase recruitment
  • Achieve larger sample sizes
  • Improve population diversity
  • Include different clinical practices
  • Capture rare events

Bioexcel Can Coordinate

  • Standardized protocol
  • Site training
  • EDC
  • Monitoring
  • Data management
  • Central project management
  • Final analysis
Medical Device Clinical Investigations

Clinical Investigations in India

Bioexcel can support:

Medical device clinical investigation conducted at an Indian site
First-in-humanEarly feasibilityPivotal studiesProspective clinical investigationsPost-market clinical investigations

Scope

  • Evidence strategy
  • CIP / protocol
  • Sample size
  • Site feasibility
  • Investigator selection
  • Ethics coordination
  • Applicable regulatory support
  • Monitoring
  • Data management
  • Biostatistics
  • Clinical Investigation Report

Can Bioexcel Conduct Medical Device Clinical Investigations in India?

Yes. Bioexcel supports medical device clinical investigations in India from study design and site feasibility through study execution, monitoring, data management, statistics and final clinical reporting.

India Regulatory Planning

Study-Specific Regulatory Assessment

The Indian regulatory pathway can vary depending on factors such as:

  • Device classification
  • Market status
  • Study objective
  • Investigational status
  • Type of clinical evidence
  • Device import or supply route
  • Study design

Bioexcel can support assessment and coordination of the appropriate clinical documentation and applicable regulatory steps.

Ethics Coordination

Ethics Support for India Studies

Bioexcel can support:

  • Ethics submission package
  • Protocol
  • ICF / PIS
  • Investigator documents
  • Site documents
  • Query responses
  • Amendments
  • Safety submissions where applicable
  • Study close-out documentation

Study-specific Ethics Committee requirements should be evaluated for each site.

PMCF in India

Post-Market Clinical Follow-Up in India

India may support PMCF where:

PMCF study conducted through an Indian clinical site
The device is already in clinical useRelevant hospitals have sufficient patient exposureLong-term follow-up is availableReal-world clinical outcomes can be collected

Potential Models

Prospective PMCFRetrospective PMCFRegistryHybrid PMCFReal-world evidence

Can Bioexcel Conduct PMCF in India?

Yes. Bioexcel supports prospective and retrospective PMCF programs in India through suitable clinical sites, including protocol development, site feasibility, monitoring, data management, biostatistics and reporting.

Retrospective PMCF in India

Existing Hospital Records as Post-Market Evidence

Retrospective PMCF can be useful where:

  • The device has several years of use
  • Implant / procedure records exist
  • Long-term follow-up is documented
  • Revision / reintervention data are available
  • Required endpoints can be abstracted
Retrospective PMCF study using Indian hospital medical records
Device UseHospital FeasibilityPatient IdentificationEthics / Data AccessData AbstractionMonitoringEDCBiostatisticsPMCF Reporting

Can Bioexcel Conduct Retrospective PMCF Using Indian Hospital Records?

Yes. Bioexcel supports retrospective PMCF using suitable Indian hospital records where the available data are relevant, sufficiently complete, ethically accessible and capable of addressing the defined clinical evidence gap.

IVD Clinical Performance in India

Clinical Performance Studies for Diagnostics

Bioexcel supports India-based IVD programs involving:

IVD clinical performance study with clinical specimens in India
  • Prospective recruitment
  • Archived specimens
  • Fresh samples
  • Positive cohorts
  • Negative cohorts
  • Comparator methods
  • Reference testing
  • Index-device testing
  • Data management
  • Biostatistics
  • CPSR

Can Bioexcel Conduct IVD Clinical Performance Studies in India?

Yes. Bioexcel supports IVD clinical performance studies in India through suitable clinical sites and laboratories, including specimen feasibility, participant recruitment, testing, data management, statistics and final reporting.

India Specimen Feasibility

Clinical Specimen & Sample Sourcing

Bioexcel can assess feasibility for:

  • Serum
  • Plasma
  • Whole blood
  • Urine
  • Saliva
  • Swabs
  • Stool
  • Other test-specific specimens

Potential Cohorts

PositiveNegativeWeak positiveNear-cutoffRare positiveDisease controlsGenotype-definedSerotype-definedCross-reactive conditions

Feasibility Checks

  • Sample count
  • Characterization
  • Volume
  • Storage
  • Freeze-thaw history
  • Clinical metadata
  • Ethics status
  • Reference-testing availability

Can Bioexcel Source IVD Samples in India?

Bioexcel can assess feasibility for prospective and archived IVD specimens in India based on sample type, target condition, characterization method, sample volume, storage history and study-specific regulatory requirements.

Reference / Comparator Testing

Diagnostic Reference Testing Coordination

Depending on the assay and study design, methods may include:

  • PCR
  • RT-PCR
  • ELISA
  • Culture
  • LC-MS/MS
  • GC-MS
  • Established laboratory analyzers
  • Other scientifically justified reference methods

Bioexcel can coordinate appropriate reference-testing workflows with suitable laboratories.

Clinical Monitoring

Medical Device Monitoring Across India

Bioexcel supports:

Clinical monitoring for a medical device study in India
  • Site initiation
  • Interim monitoring
  • Remote monitoring
  • Source-data review
  • Consent review
  • Eligibility
  • Safety
  • Device accountability
  • Protocol deviations
  • Data-query follow-up
  • Site close-out

Monitoring Models

On-siteRemoteHybridRisk-based where appropriate

Does Bioexcel Provide Medical Device Clinical Monitoring in India?

Yes. Bioexcel supports medical device clinical monitoring in India using on-site, remote or hybrid approaches depending on the study design and site requirements.

Project Management

Central Oversight Across Sites and Functions

Bioexcel project management can coordinate:

  • Study timelines
  • Site activation
  • Recruitment
  • Monitoring
  • Safety
  • Protocol deviations
  • Data queries
  • Vendors
  • Investigators
  • Sponsor communication
  • Database lock
  • Final reporting
SponsorBioexcel Project ManagerSites | Monitoring | Data | Statistics | Medical WritingFinal Evidence
Clinical Data Management

India Execution With Centralized Data Control

  • Data Management Plan
  • CRF / eCRF
  • EDC
  • Edit checks
  • Data review
  • Query management
  • Safety reconciliation
  • Data cleaning
  • Database lock
  • Statistical transfer

Yes. Bioexcel provides eCRF design, EDC configuration, clinical data management, query management, data cleaning and database lock for India-based medical device and IVD studies.

Biostatistics

Medical Device & IVD Statistics

  • Sample size
  • Endpoint strategy
  • SAP
  • Safety analysis
  • Performance analysis
  • Survival analysis
  • PMCF analysis
  • Sensitivity/specificity
  • PPA/NPA
  • TLFs
  • Statistical interpretation
Medical Writing

Clinical Documentation From Protocol to Final Report

  • Study synopsis
  • CIP
  • Protocol
  • CPSP
  • ICF/PIS
  • CIR
  • CPSR
  • PMCF Evaluation Report
  • CER input
  • Regulatory response
India Data for EU MDR

Can Clinical Data Generated in India Support EU MDR?

Potentially, yes.

The relevance of Indian clinical data should be evaluated based on:

  • Study design
  • Ethical conduct
  • Data integrity
  • Target population
  • Clinical practice
  • Device applicability
  • Intended purpose
  • Endpoint relevance
  • Follow-up
  • Regulatory objective

Can Indian Clinical Data Be Used for EU MDR?

Clinical data generated in India may potentially support EU MDR clinical evaluation when the evidence is scientifically valid, ethically generated, relevant to the intended population and suitable for the device's intended purpose and clinical claims. Acceptability should be assessed case by case.

India Data for FDA / Global Use

Build the Study Around the Target Market

Where a sponsor intends to use clinical data internationally, Bioexcel can assess:

  • Regulatory objective
  • Study design requirements
  • Population relevance
  • Endpoints
  • Follow-up
  • Statistical design
  • Data quality
  • Reporting standards

A study should be designed prospectively around the intended regulatory use rather than assuming that all datasets are interchangeable.

India + Europe Evidence Model

Use Each Geography Where It Adds the Most Value

India

  • Patient access
  • Procedure volume
  • Retrospective records
  • IVD samples
  • Central operations

Europe

  • European population
  • Local PMCF
  • Intended-user evidence
  • Layperson studies
  • Regional clinical sites

Bioexcel Central Evidence Team

ProtocolProject managementEDCDataBiostatisticsMedical writingCER / PER / PMCF

↓ One Integrated Global Evidence Program

Can Bioexcel Combine India and European Clinical Evidence?

Yes. Bioexcel can support programs that use Indian and European clinical resources for different evidence needs, provided the overall study and regulatory strategy scientifically justifies the populations, data sources and intended use of the evidence.

Therapeutic Expertise

Medical Device Clinical Research Across Major Specialties

Cardiovascular & Structural Heart

StentsBalloonsCathetersOccludersImplantable devices

Orthopedics & Spine

Joint implantsTraumaSpine devices

Surgical Robotics

Robotic surgical systemsClinical investigationPMCFHuman factors

Urology

CathetersStentsImplantable devices

Wound Care

Wound management devicesDressingsSurgical products

Diagnostics / IVD

Rapid testsMolecular testsPOCTSelf-testing

Digital Health & AI

SaMDAI-enabled devicesDigital diagnostics
India Delivery Models

Flexible Clinical Support

Model 1 — Full-Service CRO

Bioexcel supports strategy through final report.

Model 2 — Clinical Operations Only

Bioexcel manages sites and monitoring.

Model 3 — Sponsor-Selected Site

Sponsor provides hospital; Bioexcel supports execution.

Model 4 — Biometrics Only

Bioexcel provides EDC, data management and statistics.

Model 5 — India + Europe Hybrid

Functions are allocated across regions according to scientific and operational need.

Why MedTech Sponsors Use Bioexcel for India Programs

Bioexcel India clinical research delivery team

Medical Device & IVD Focus

Programs are designed around MedTech evidence requirements.

Site Feasibility

Hospital and investigator selection based on real study requirements.

Full Evidence Lifecycle

Strategy, clinical operations, data, statistics and reporting can remain connected.

Prospective + Retrospective Capability

Flexible study models according to the evidence gap.

IVD Specimen Capability

Support for prospective and archived sample programs.

Global Evidence Orientation

India programs can be designed with EU, US or broader regulatory objectives in mind.

Client Success

India Clinical Evidence Programs in Practice

Cardiovascular Clinical Investigation

Requirement: Device: Cardiovascular device

Model: Prospective study — Bioexcel Scope: Protocol, sites, monitoring, data, statistics and report

Retrospective Implant PMCF

Requirement: Long-term device outcomes

Data Source: Hospital records — Bioexcel Scope: Feasibility, abstraction, monitoring, EDC and analysis

IVD Performance Study

Requirement: Characterized positive and negative specimens

Bioexcel Scope: Sample strategy, reference testing, device testing and statistics

Sponsor-Selected Site Program

Requirement: Model: Sponsor identified hospital

Bioexcel Scope: Operational support, monitoring, data and reporting

Frequently Asked Questions About Medical Device Clinical Research in India

Yes. Bioexcel specializes in medical device and IVD clinical evidence programs, including clinical investigations, PMCF, monitoring, data management, statistics and medical writing.

HIPAA Compliant
ICH-GCP Compliant
FDA 21 CFR Part 11
ISO 9001
ISO 14155
ISO 27001 Certified
EU MDR 2017/745
EU IVDR 2017/746
US FDA Requirements
ISO 20916

Bioexcel combines India clinical execution with specialized medical-device, IVD, data and regulatory evidence expertise.

Regulatory Evidence RequirementIndia FeasibilityHospital / Investigator SelectionEthics / Regulatory PlanningStudy ExecutionMonitoringEDC / Data ManagementBiostatisticsClinical ReportCER / PMCF / PER / Global Regulatory Evidence